Clinical efficacy of TACE combined with Apatinib in the treatment of advanced hepatocellular carcinoma.

CONCLUSIONS: The therapeutic efficacy of TACE combined with Apatinib in HCC treatment is higher compared to TACE alone, which may be related to the inhibition of tumor angiogenesis. TACE combined with Apatinib can improve the prognosis and prolong the overall survival (OS) of HCC patients. PMID: 31128013 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research